英文名称 | NIK SMI1 |
---|
IUPAC Name | 6-(3-{2-[(3R)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl}phenyl)-4-methoxypyridine-2-carboxamide |
---|---|
INCHI | InChI=1S/C20H19N3O4/c1-23-9-8-20(26,19(23)25)7-6-13-4-3-5-14(10-13)16-11-15(27-2)12-17(22-16)18(21)24/h3-5,10-12,26H,8-9H2,1-2H3,(H2,21,24)/t20-/m0/s1 |
InChi Key | LQSHXYHWYGKAMX-FQEVSTJZSA-N |
Canonical SMILES | COc1cc(nc(c1)c1cccc(c1)C#C[C@]1(O)CCN(C1=O)C)C(=O)N |
PubChem CID | 117902000 |
PubChem CID | 117902000 |
---|
Ligand ID | 9964 |
---|---|
名称 | NIK SMI1 |
类别 | Synthetic organic |
学名 | 6-(3-{2-[(3R)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl}phenyl)-4-methoxypyridine-2-carboxamide |
生物活性评价 |
In a screening panel NIK SMI1 inhibited just 3 off-target kinases, KHS1 (MAP4K5), LRRK2, and PKD1 (PRKD1), by >75% at 1 μM, out of 222 kinases tested. Ki determination established NIK SMI1's selectivity over these off-targets |
评价 |
NIK SMI1 is a selective inhibitor of the NF-κB-inducing kinase, NIK (MAP3K14) |
1. Brightbill HD, Suto E, Blaquiere N, Ramamoorthi N, Sujatha-Bhaskar S, Gogol EB, Castanedo GM, Jackson BT, Kwon YC, Haller S et al.. (2018) NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus.. Nat Commun, 9 (1): (179). [PMID:29330524] |